Kenneth Bate - Jun 2, 2021 Form 4 Insider Report for CATABASIS PHARMACEUTICALS INC (ATXS)

Role
Director
Signature
/s/ Ben Harshbarger, as attorney-in-fact for Kenneth Bate
Stock symbol
ATXS
Transactions as of
Jun 2, 2021
Transactions value $
$0
Form type
4
Date filed
6/2/2021, 07:16 PM
Next filing
Jun 9, 2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ATXS Stock Option (right to buy) Award $0 +100K $0.00 100K Jun 2, 2021 Common Stock 100K $2.04 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option was granted on June 2, 2021 and is schedule to vest in equal annual installments over a three-year period from the date of grant, subject to the director's continued service.